Home › Research › Prevention trials
Management of mild cognitive impairment (MCI): The need for national and international guidelines
Siegfried F. Kasper, C. Bancher, Anne Eckert, Hans Förstl, Lutz Frölich, Jakub Hort, Amos D. Korczyn, Reto Werner Kressig et al.. The World Journal of Biological Psychiatry, 2020-02-05
Topic: Drug trials: efficacy and safety
Plain-language summary
Consensus diagnostic criteria for MCI are available, making early recognition and accurate classification of MCI subtypes possible. MCI can be identified in a primary care setting. Further corroboration and differential diagnosis should be done at specialist level. Mixed pathologies are the rule in MCI, thus a multi-target treatment approach is a rational strategy. Promising evidence has been generated for multi-domain interventions. Limited evidence is available for different pharmacological classes that have been investigated in MCI clinical trials (e.g. acetylcholinesterase inhibitors). EGb 761® improved symptoms in some clinical trials; it is the only pharmacological treatment recommended in existing guidelines for the symptomatic treatment of MCI. MCI is recognised as an important treatment target and some recent national guidelines have considered symptomatic treatment recommendations for MCI. However, more needs to be done, especially at an international level.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Kasper, S. F., Bancher, C., Eckert, A., Förstl, H., Frölich, L., Hort, J., et al. (2020). Management of mild cognitive impairment (MCI): The need for national and international guidelines. The World Journal of Biological Psychiatry. https://doi.org/10.1080/15622975.2019.1696473
Vancouver
Kasper SF, Bancher C, Eckert A, Förstl H, Frölich L, Hort J, et al. Management of mild cognitive impairment (MCI): The need for national and international guidelines. The World Journal of Biological Psychiatry. 2020. doi:10.1080/15622975.2019.1696473. PMID: 32019392.
BibTeX
@article{kasper2020-32019392,
author = {Kasper, Siegfried F. and Bancher, C. and Eckert, Anne and Förstl, Hans and Frölich, Lutz and Hort, Jakub and Korczyn, Amos D. and Kressig, Reto Werner and others},
title = {{Management of mild cognitive impairment (MCI): The need for national and international guidelines}},
journal = {The World Journal of Biological Psychiatry},
year = {2020},
doi = {10.1080/15622975.2019.1696473},
pmid = {32019392},
url = {https://doi.org/10.1080/15622975.2019.1696473}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Consensus diagnostic criteria for MCI are available, making early recognition and accurate classification of MCI subtypes possible.
- MCI can be identified in a primary care setting.
- Further corroboration and differential diagnosis should be done at specialist level.
- Mixed pathologies are the rule in MCI, thus a multi-target treatment approach is a rational strategy.
- Promising evidence has been generated for multi-domain interventions.
New to this subject? Start with our plain-English guide: Prevention →
Study details
- Evidence strengthLow
How this study scored 41/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 24 of the 58 points we could judge it on, which is 41 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (The World Journal of Biological Psychiatry) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2020 — within 10 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 32019392) |
| Free to read | 2 / 2 | Free to read |
| Points | 24 / 58 | Scored on 11 of 20 parts. We have no data for the rest, so they are left out: 24 of the 58 points we could judge it on is 41 out of 100. |
| Total | 41 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Prevention trials from nearby years
Also tagged “cholinesterase”
272 studies in the library carry the topic tag “cholinesterase”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 272 tagged studies.